CaridianBCT initiates whole blood process with Mirasol PRT study (Pharmaceutical Business Review)
CaridianBCT, a developer and marketer of blood collection and processing systems to hospitals and blood banks, has initiated a clinical trial for treating whole blood with Mirasol pathogen reduction technology after receiving clearance from the FDA and US Department of Defense.

GSK Update On FDA Review Of Promacta (eltrombopag) (Medical News Today)
GlaxoSmithKline announced that the United States Food and Drug Administration (FDA)continues to review the new drug application for Promacta (eltrombopag) beyond the September 19, 2008 action date.

ALIMTA given FDA nod for first-line treatment of non-small cell lung cancer (CancerFacts.com)
INDIANAPOLIS Oct. 2, 2008 (cancerfacts.com) The FDA has approved premetrexed (ALIMTA ) in combination with cisplatin for the first-line treatment of a specific type of locally-advanced non-small cell lung cancer.